Global Health Limited

BSE: MEDANTA543654ISIN INE474Q01031

Healthcare
Hospital
BSE 500

Share price

₹1,401.45+74.80 (+5.64%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,542.00
52W low: ₹955.20
Off 52W high: -9.11%
1M return: +5.24%
3M return: -0.64%
6M return: +18.62%
1Y return: +12.21%
20D avg volume: 79,781
50 DMA: ₹1,373.60
200 DMA: ₹1,246.21

Key ratios Consolidated

Market cap: ₹37,682 Cr
Current price: ₹1,401.45
52W high / low: ₹1,542.00 / ₹955.20
Face value: ₹2.00
P/E: 61.46
P/B: 8.71
EPS (TTM): ₹22.80
Book value / share: ₹160.92
ROE: —
ROCE: 15.00%
Operating margin: —
Net margin: —
Debt / equity: 0.30
Net debt: ₹1,063 Cr
Interest cover: 10.04
Dividend yield: 0.04%
Dividend / share (TTM): ₹0.50
Payout: 2.19%
Cash conversion cycle: 20.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	1,469	1,304	1,159	1,121	1,099	1,031	931.25	943.44	956.55	861.08	808.63	832.60
	23.61	22.16	36.74	21.78	19.73	20.46	22.93	16.02	18.22	21.93	27.42	21.93
	1,493	1,326	1,196	1,143	1,119	1,051	954.18	959.46	974.77	883.00	836.05	854.53
	1,198	1,113	1,009	986.45	935.12	862.75	770.84	770.39	793.67	739.35	692.97	682.17
	278.68	257.19	215.65	226.72	226.69	213.08	191.48	206.60	204.28	187.60	176.52	172.24
	45.81	40.73	27.80	28.93	28.78	31.79	20.51	20.70	28.15	23.10	17.57	18.13
	334.61	319.27	284.70	280.67	274.33	256.40	204.05	205.02	214.29	201.19	187.80	184.86
	28.09	26.68	26.71	21.51	17.11	13.79	15.03	16.27	15.97	17.98	18.23	17.68
	70.80	68.98	66.52	61.19	49.73	45.11	49.25	48.45	49.43	46.62	45.45	43.98
	443.09	403.65	384.06	367.42	338.39	308.39	288.89	143.10	157.58	141.32	127.90	127.76
	294.83	213.26	187.28	156.38	183.83	188.55	183.33	189.07	181.10	143.65	143.09	172.37
	0.00	0.00	0.00	-36.60	15.98	19.59	-49.90	0.00	0.00	0.00	0.00	0.00
	294.83	213.26	187.28	119.78	199.81	208.14	133.44	189.07	181.10	143.65	143.09	172.37
	75.68	56.01	45.63	24.75	41.41	49.16	32.06	46.21	50.28	37.39	15.74	48.82
	219.14	157.25	141.65	95.03	158.40	158.98	101.38	142.86	130.82	106.26	127.35	123.54
	8.21	5.91	5.36	3.54	5.89	5.92	3.77	5.32	4.87	3.96	4.74	4.61
Key metrics
	393.72	308.92	280.51	202.48	266.65	267.04	197.72	253.79	246.50	208.25	206.77	234.03
	26.80%	23.70%	24.20%	18.10%	24.30%	25.90%	21.20%	26.90%	25.80%	24.20%	25.60%	28.10%
	14.90%	12.10%	12.20%	8.50%	14.40%	15.40%	10.90%	15.10%	13.70%	12.30%	15.70%	14.80%
	5.50%	—	4.10%	—	4.60%	—	3.60%	—	—	—	—	—
	33.60%	26.50%	24.50%	18.80%	14.90%	19.70%	15.20%	13.30%	—	—	—	—
	38.30%	-1.10%	39.70%	-33.50%	21.10%	49.60%	-20.40%	15.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	5,053	4,410	3,692	3,275	2,694
	104.29	98.59	79.10	74.66	64.92
	5,157	4,509	3,771	3,350	2,759
	4,306	3,793	3,074	2,723	2,310
	978.24	882.13	789.96	687.69	571.12
	143.27	117.30	92.46	73.97	55.74
	1,219	1,096	824.54	734.86	634.35
	102.99	79.11	65.26	73.91	77.92
	267.49	222.54	193.75	172.73	149.91
	1,598	1,398	1,111	525.48	481.78
	851.75	716.04	697.15	627.10	449.29
	-36.60	-1.02	-49.90	0.00	0.00
	815.15	715.02	647.26	627.10	449.29
	202.07	160.95	165.94	149.04	123.21
	613.07	554.07	481.32	478.06	326.08
	23.02	20.71	17.92	17.80	12.58
Key metrics
	1,186	1,017	906.27	873.74	677.12
	23.46%	23.10%	24.50%	26.70%	25.10%
	12.13%	12.60%	13.00%	14.60%	12.10%
	—	15.00%	17.20%	—	—
	26.18%	19.40%	12.70%	21.60%	—
	9.16%	15.10%	0.70%	46.60%	—
	—	-123.80	107.22	—	—
	—	1.29	1.30	—	—
	—	0.30	0.10	—	—
	—	1,063	97.68	—	—
	—	20.4	16.2	—	—
Balance sheet
	—	5,905	4,766	—	—
	—	1,675	1,533	—	—
	—	127.33	230.20	—	—
	—	411.19	291.86	—	—
	—	78.98	67.14	—	—
	—	—	18.99	—	—
	—	3,779	1,975	—	—
	—	242.37	194.81	—	—
	—	627.13	618.82	—	—
	—	1,190	327.88	—	—
	—	62.99	63.78	—	—
	—	1,127	264.10	—	—
	—	3,984	3,388	—	—
Cash flow
	—	714.39	623.76	—	—
	—	-1,065	-720.94	—	—
	—	247.85	-97.23	—	—
	—	838.19	516.54	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	1,208	1,079	960.63	940.16	926.43	882.16	802.87	624.40	664.61	611.45	578.64	561.68
	25.89	24.06	35.80	24.66	22.80	23.14	25.67	22.17	23.58	26.70	32.55	25.83
	1,234	1,103	996.43	964.83	949.23	905.29	828.53	646.57	688.18	638.15	611.19	587.51
	990.91	919.67	832.96	826.74	780.17	726.64	652.75	514.26	544.58	508.40	486.03	466.64
	244.62	226.16	188.64	201.83	203.22	192.16	172.38	148.92	152.11	140.56	133.79	125.45
	0.01	0.00	0.01	-0.57	0.04	2.56	5.82	11.09	11.78	11.69	9.95	10.11
	301.40	285.47	255.68	252.30	248.33	232.94	185.42	158.23	168.10	157.50	149.17	147.12
	17.07	15.89	13.46	13.08	8.88	5.66	7.10	5.94	5.37	5.95	6.21	5.76
	56.15	54.60	52.21	47.86	37.43	33.41	37.98	23.44	24.91	23.30	23.39	21.73
	371.67	337.55	322.97	311.64	282.30	255.95	240.85	98.65	110.65	100.96	92.86	90.34
	243.08	183.11	163.47	138.09	169.06	178.65	175.78	132.31	143.61	129.74	125.17	120.87
	0.00	0.00	0.00	-35.20	15.98	19.59	-49.90	—	—	—	—	—
	243.08	183.11	163.47	102.89	185.05	198.25	125.89	132.31	143.61	129.74	125.17	120.87
	61.82	45.80	39.34	22.98	44.85	46.28	32.48	33.01	39.14	33.46	32.93	33.53
	181.26	137.31	124.13	79.91	140.20	151.96	93.41	99.31	104.47	96.28	92.24	87.34
	6.75	5.11	4.62	2.97	5.22	5.66	3.48	3.70	3.89	3.58	3.43	3.25
Key metrics
	316.30	253.60	229.14	163.83	231.36	237.32	170.97	161.69	173.89	158.99	154.77	148.36
	26.20%	23.50%	23.90%	17.40%	25.00%	26.90%	21.30%	25.90%	26.20%	26.00%	26.70%	26.40%
	15.00%	12.70%	12.90%	8.50%	15.10%	17.20%	11.60%	15.90%	15.70%	15.70%	15.90%	15.50%
	4.90%	—	3.70%	—	4.40%	—	3.40%	—	—	—	—	—
	30.40%	22.30%	19.60%	50.60%	39.40%	44.30%	38.80%	11.20%	—	—	—	—
	29.30%	-9.60%	32.90%	-19.50%	34.20%	57.80%	1.30%	13.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	4,188	3,709	3,204	2,280	1,959
	110.41	106.41	90.93	102.87	61.68
	4,298	3,816	3,295	2,383	2,021
	3,570	3,167	2,622	1,894	1,669
	861.25	785.86	715.81	506.15	430.10
	-0.55	1.94	40.39	42.34	35.90
	1,095	989.26	746.29	591.06	531.63
	59.50	41.09	33.39	24.46	26.16
	210.82	170.91	149.61	87.09	86.09
	1,344	1,173	934.01	382.79	368.30
	727.75	649.28	672.94	488.67	351.70
	-35.20	0.38	-49.90	—	—
	692.55	649.65	623.05	488.67	351.70
	169.94	153.45	161.52	127.78	88.46
	522.61	496.20	461.53	360.89	263.25
	19.45	18.46	17.18	13.44	10.16
Key metrics
	962.87	861.65	806.05	600.22	463.95
	22.99%	23.20%	25.20%	26.30%	23.70%
	12.48%	13.40%	14.40%	15.80%	13.40%
	—	14.30%	16.70%	—	—
	29.41%	15.80%	40.50%	16.40%	—
	7.78%	7.50%	27.90%	37.10%	—
	—	-102.24	99.98	—	—
	—	1.16	1.14	—	—
	—	0.17	0.04	—	—
	—	586.75	-49.62	—	—
	—	23.2	19.6	—	—
Balance sheet
	—	5,351	4,441	—	—
	—	1,570	1,453	—	—
	—	95.91	190.06	—	—
	—	386.85	291.59	—	—
	—	50.90	48.99	—	—
	—	—	16.14	—	—
	—	2,889	1,466	—	—
	—	202.09	168.68	—	—
	—	531.11	518.83	—	—
	—	682.66	140.44	—	—
	—	28.59	26.13	—	—
	—	654.07	114.31	—	—
	—	4,013	3,498	—	—
Cash flow
	—	573.32	527.67	—	—
	—	-931.35	-638.20	—	—
	—	263.88	-94.49	—	—
	—	675.56	427.69	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +23.71%
Sales CAGR 5Y: —
Profit CAGR 3Y: +23.53%
Profit CAGR 5Y: —
Sales YoY (TTM): +29.41%
Profit YoY (TTM): +7.78%

Consolidated

Sales CAGR 3Y: +17.85%
Sales CAGR 5Y: —
Profit CAGR 3Y: +19.33%
Profit CAGR 5Y: —
Sales YoY (TTM): +26.18%
Profit YoY (TTM): +9.16%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 33.00%

Quarter	30 Sep 2026	September 2026	June 2026
Promoter %	33.00%	33.00%	33.00%

Holder	Type	Holding	Previous	Change
NARESH KUMAR TREHAN	Promoter	33.00%	33.00%	0.00%
DUNEARN INVESTMENTS (MAURITIUS) PTE LTD	Public	14.84%	14.84%	0.00%
SUNIL SACHDEVA	Public	10.04%	10.04%	0.00%
RJ CORP LIMITED	Public	6.58%	6.58%	0.00%
INVESCO INDIA BUSINESS CYCLE FUND	Public	5.17%	5.17%	0.00%
KOTAK CONTRA FUND	Public	3.43%	3.43%	0.00%
GOVERNMENT PENSION FUND GLOBAL	Public	3.09%	3.09%	0.00%
UTI-FLEXI CAP FUND	Public	2.00%	2.00%	0.00%
POLARIS HEALTHCARE INVESTMENTS PTE LTD	Public	1.86%	1.86%	0.00%
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO CONSER	Public	1.72%	1.72%	0.00%
HDFC VALUE FUND	Public	1.11%	1.11%	0.00%
Naresh Trehan HUF	Promoter Group	0.00%	0.00%	0.00%
Metamorphosis Learning Private Limited	Promoter Group	0.00%	0.00%	0.00%
Madhu Trehan	Promoter Group	0.00%	0.00%	0.00%
SA Family Trust	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation under Regulation 30 of SEBI Listing regulations, 2015 - Audio Recording.4 Nov 2026 · Company Update / Analyst / Investor Meet
Newspaper publication under Regulation 30 and 47 of SEBI Listing Regulations.4 Nov 2026 · Company Update / Newspaper Publication
Investor Presentation for the Second Quarter and Half Year ended September 30, 2026, Results.3 Nov 2026 · Company Update / Investor Presentation
Press Release for the Second Quarter and Half Year ended on September 30, 2026 Results.3 Nov 2026 · Company Update / Press Release / Media Release
Announcement under Regulation 30 of Listing Regulations for capacity addition at proposed Hospital in Ghaziabad.3 Nov 2026 · Company Update / General
Results for the Quarter and Half Year ended September 30, 20263 Nov 2026 · Result / Financial Results
Outcome of Board Meeting held on November 03, 2026, to consider and approved the unaudited financial Results for the Quarter & Half year ended September 30, 2026.3 Nov 2026 · Board Meeting / Outcome of Board Meeting
Announcement Regarding Change in Management2 Nov 2026 · Company Update / Change in Management
It is informed that Nomination and Remuneration Committee in its Meeting held today i.e November 02, 2026, has made a grant of 3,14,000 ESOPs under GHL LTIP 2024.2 Nov 2026 · Company Update / Meeting Updates
Announcement regarding Change in Management.31 Oct 2026 · Company Update / Change in Management
Announcement under SEBI Listing Regulation regarding schedule of Institutional investor meet.27 Oct 2026 · Company Update / Analyst / Investor Meet
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding allotment of Shares.23 Oct 2026 · Company Update / Allotment of ESOP / ESPS
Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Global Health Limited has informed ....22 Oct 2026 · Board Meeting / Board Meeting
Please find attached herewith the Certificates issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 by RTA for the Quarter ended September 30, 2026.12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation Under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating assigned by Crisil ESG Ratings & Analytics Limited.5 Oct 2026 · Company Update / General
Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisition of 10,560 Sq. Meter Land Parcel in Ghaziabad.29 Sep 2026 · Company Update / Press Release / Media Release
Intimation Under Regulation 30 of Listing Regulations.28 Sep 2026 · Company Update / General
Intimation regarding closure of Trading Window for the Second Quarter ended on September 30, 2026.24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.22 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation under Regulation 30 of Listing Regulations regarding allotment of shares.22 Sep 2026 · Company Update / Allotment of ESOP / ESPS
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.17 Sep 2026 · Company Update / Analyst / Investor Meet
Enclosed Scrutinizer Report and Voting Results of 22nd Annual General Meeting of the Company.16 Sep 2026 · AGM/EGM / AGM
Proceeding of 22nd Annual General Meeting of the Company held on September 16, 2026, at 12:00 Noon.16 Sep 2026 · AGM/EGM / AGM
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.11 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.11 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.10 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.9 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.3 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.3 Sep 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.31 Aug 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.31 Aug 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.25 Aug 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.22 Aug 2026 · Company Update / Analyst / Investor Meet
Announcement under SEBI Listing Regulations regarding Schedule of Institutional Investor Meet.22 Aug 2026 · Company Update / Analyst / Investor Meet
Post Dispatch Advertisement for the 22nd Annual General Meeting for the Financial Year 2025-26.22 Aug 2026 · Company Update / Newspaper Publication
Enclosed.21 Aug 2026 · Company Update / General
Business Responsibility and Sustainability Report along with Assurance Report for the Financial Year 2025-26.21 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please find enclosed herewith the Annual Report along with BRSR and AGM Notice for Financial Year 2025-26.21 Aug 2026 · Others / Reg. 34 (1) Annual Report
Enclosed21 Aug 2026 · AGM/EGM / AGM
Announcement under SEBI Listing Regulations regarding Schedule of Analyst Meet.18 Aug 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.5000	14 Aug 2026	14 Aug 2026	—
Final Dividend - Rs. - 0.5000	22 Aug 2025	22 Aug 2025	—

Board meetings

3 Nov 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results